Cytokeratin 1 (Suprabasal Keratinocyte Marker) Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-Cytokeratin 1 (Suprabasal Keratinocyte Marker) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | Cytokeratin 1 (Suprabasal Keratinocyte Marker) |
| Clone | [LHK1] |
| Host Species | Mouse |
| Reactive Species | human, rat |
| Isotype | IgG2a, kappa |
| Format | purified |
| Size | 0.02 mg (With BSA & Azide at 0.2mg/ml), 0.1 mg (With BSA & Azide at 0.2mg/ml), 0.1 mg (Without BSA & Azide at 1mg/ml) |
| Concentration | n/a |
| Applications | Immunohistochemistry (IHC) Paraffin |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Specificity: Keratins are a family of intermediate filament proteins that assemble into filaments through forming heterodimers of one type I keratin (keratins 9 to 23) and one type II keratin (keratins 1 to 8). Keratins demonstrate tissue and differentiation specific expression profiles. Cytokeratin 1 is a hetero-tetramer of two type I as well as two type II keratins, keratin-10 (KRT10). Keratin 1 is differentiation specific keratin that is one of the predominant keratins in suprabasal keratinocytes in stratified epithelia. Mutations in keratin 1 cause epidermolytic hyperkeratosis. |
| Immunogen | Immunogen: A 13-amino acid peptide (VRFVSTSYSGVTR) from the C-terminus of human KRT1 protein |
| Other Names | [67kDa Cytokeratin; CK1; Cytokeratin-1; EHK1; Epidermolytic hyperkeratosis 1; EPPK; K1; Keratin Type II Cytoskeletal 1; Keratin-1; KRT1; KRT1A; NEPPK; Type II cytoskeletal 1; Type-II keratin Kb1] |
| Gene, Accession # | [KRT1], Gene ID: 3848, NCBI: NP_006112.3, UniProt: P04264 |
| Catalog # | MBS4381043 |
| Price | $190, $340, $340 |
| Order / More Info | Cytokeratin 1 (Suprabasal Keratinocyte Marker) Antibody from MYBIOSOURCE INC. |
| Product Specific References | 1. Machesney et al. 1998. Am J Pathol. 152(5):1133-41. 2. Waseem et al. 1999. J Invest Dermatol. 112(3):362-9. 2. Leigh et al. 1993. Br J Dermatol. 129(2):110-9. 3. Bloor et al. 2003. Am J Pathol. 162(3):963-75. |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies